The Mounjaro Microdosing Chart Explained: Doses, Steps and What the Evidence Says

Step 1: Start at 2.5mg, and understand why this dose exists

The first thing any credible microdosing tirzepatide chart should tell you is that 2.5mg is not a therapeutic target. It is the body's introduction to tirzepatide, a ramp designed to reduce the nausea, vomiting and other gastrointestinal effects that are more likely if treatment starts too high. Many people feel little at this stage in terms of appetite change, and that is expected. The dose is confirmed in the Mounjaro SmPC on the eMC, which is the authoritative source for exactly how the medicine should be administered and stored.

Understanding this framing matters because some charts circulating online compress or skip this phase, presenting it as optional. It is not. A prescriber may choose to extend the time at 2.5mg if your tolerance warrants it, or if there are clinical reasons to hold. That decision belongs to the clinician reviewing your case, not a downloadable PDF.

If you want a fuller picture of how tirzepatide works at each stage (mechanism, dual-receptor action, what changes between doses) our overview of tirzepatide covers the pharmacology in plain terms.

Step 2: Progress through the schedule, typically every four weeks

After the 2.5mg phase, the licensed schedule increases in 2.5mg increments: 5mg, 7.5mg, 10mg, 12.5mg, and up to 15mg as the maximum. The standard minimum period at each dose is roughly four weeks, though prescribers may recommend a longer hold if side effects are still noticeable or if a clinical review raises a concern. This is where the phrase "microdosing Mounjaro" sometimes gets applied, the idea of deliberately staying at a lower dose for longer than the standard schedule to manage tolerability.

That approach is not automatically wrong, but it has important implications. Staying at a sub-therapeutic dose for an extended period means less appetite suppression, potentially slower progress, and a longer runway before you know how your body responds at the effective range. For most people, the licensed titration pace is already cautious by design. If you are finding side effects difficult at a given step, that is exactly the kind of conversation to have with your prescriber, not a reason to redesign the schedule using a chart from a forum.

Our more detailed Mounjaro dosing chart page sets out the full schedule with clinical context, if you want a step-by-step reference.

Step 3: What happens at each dose increase, and what triggers a pause

Each step in the microdosing tirzepatide chart represents a meaningful increase in receptor activity. Weight-loss progress typically accelerates at higher doses; SURMOUNT-1 (the pivotal 72-week trial published in the New England Journal of Medicine) recorded average body-weight reductions of around 20–21% at 15mg, with most of the meaningful reduction occurring in the middle and upper dose range. Starting figures are cited as "in clinical trials" for good reason: individual responses vary considerably, and a chart cannot predict where you personally land.

A dose increase may be paused if side effects have not settled, if there is a change in health status, or if your prescriber's review identifies a reason to hold. At a regulated UK pharmacy, this review happens before any new pen is dispatched, it is not a formality. If you are paying for treatment privately, understanding what that cost includes is worth doing before you commit, because aftercare and clinical re-review at each step are what separate safe private treatment from purchasing a pen through an unverified source.

Some people also have specific questions about tirzepatide and certain health considerations, if you have come across concerns about Mounjaro and blood clots, for example, that is the kind of thing a prescriber addresses in the clinical review before treatment starts or resumes.

Microdosing Mounjaro in practice: what the online conversation misses

The phrase "microdosing" is borrowed from a different clinical context and applied loosely to tirzepatide. What most people mean by it is either staying at a lower dose longer than the standard schedule suggests, or splitting usage in ways the pen is not designed for. The KwikPen delivers one fixed weekly dose; it is not designed for fractional administration. Any approach that involves attempting to administer a partial dose from a pre-filled pen carries real risks around inaccurate dosing and contamination, and falls well outside the licensed method of use.

This is where forum-based microdosing charts can become genuinely problematic. The forum conversation around Mounjaro microdosing covers a wide range of approaches, some of which are not consistent with how the medicine is licensed in the UK. Reading that discussion alongside clinical guidance gives a more balanced picture. If the appeal of a slower titration is about managing side effects, the right route is to raise that with your prescriber, who can discuss whether extending time at a given licensed dose is appropriate for you specifically.

For a broader grounding in how Mounjaro works as a treatment (including eligibility, the NHS versus private route, and what to expect) that resource covers the full picture. The NHS provides its own accessible guidance through the NHS tirzepatide medicine page, which is a reliable first port of call for questions about how the medicine is used and what side effects to watch for.

If you want your situation reviewed by a real clinician rather than working from a chart, speak to our prescribers through a free consultation. It takes a few minutes, it is reviewed the same day by a named GPhC-registered prescriber, and it gives you a clinical answer grounded in your actual health picture, not a generic dose ladder.

One practical note: if you are planning to start treatment or increase your dose around a bank holiday, a payday at the end of the month, or any other busy week, factor in the timing early. Orders placed before 12pm on a working day are dispatched the same day once approved, but holidays affect DPD delivery windows.